FDA Approved: CLOBETASOL PROPIONATE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved CLOBETASOL PROPIONATE as an original-application generic topical product. The approval holder is Taro Pharmaceuticals U.S.A., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis
• Psoriasis

Drugs mentioned

• CLOBETASOL PROPIONATE (Clobetasol propionate)

Snippet

ORIG AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)